These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

546 related items for PubMed ID: 23834988

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A real-world evaluation of oral vancomycin for severe Clostridium difficile infection: implications for antibiotic stewardship programs.
    Le F, Arora V, Shah DN, Salazar M, Palmer HR, Garey KW.
    Pharmacotherapy; 2012 Feb; 32(2):129-34. PubMed ID: 22392421
    [Abstract] [Full Text] [Related]

  • 3. High frequency of nonadherence to Clostridium difficile treatment guidelines.
    McEllistrem MC, McGraw M, Sahud AG, Chan-Tompkins NH, Goswami R, Bhanot N.
    South Med J; 2014 Sep; 107(9):597-9. PubMed ID: 25188627
    [Abstract] [Full Text] [Related]

  • 4. Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship.
    Harpe SE, Inocencio TJ, Pakyz AL, Oinonen MJ, Polk RE.
    Pharmacotherapy; 2012 Aug; 32(8):744-54. PubMed ID: 23307522
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Assessment of 30-day all-cause mortality in metronidazole-treated patients with Clostridium difficile infection.
    Venugopal AA, Szpunar S, Sanchez K, Sessions R, Johnson LB.
    Scand J Infect Dis; 2013 Oct; 45(10):786-90. PubMed ID: 23746336
    [Abstract] [Full Text] [Related]

  • 7. Diagnosis and management of Clostridium difficile infection.
    Dupont HL.
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1216-23; quiz e73. PubMed ID: 23542332
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of treatment outcomes with vancomycin alone versus combination therapy in severe Clostridium difficile infection.
    Bass SN, Bauer SR, Neuner EA, Lam SW.
    J Hosp Infect; 2013 Sep; 85(1):22-7. PubMed ID: 23876778
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of vancomycin dose on treatment outcomes in severe Clostridium difficile infection.
    Lam SW, Bass SN, Neuner EA, Bauer SR.
    Int J Antimicrob Agents; 2013 Dec; 42(6):553-8. PubMed ID: 24103633
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Rifaximin in the treatment of recurrent Clostridium difficile infection.
    Mattila E, Arkkila P, Mattila PS, Tarkka E, Tissari P, Anttila VJ.
    Aliment Pharmacol Ther; 2013 Jan; 37(1):122-8. PubMed ID: 23095030
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.
    Pépin J, Valiquette L, Alary ME, Villemure P, Pelletier A, Forget K, Pépin K, Chouinard D.
    CMAJ; 2004 Aug 31; 171(5):466-72. PubMed ID: 15337727
    [Abstract] [Full Text] [Related]

  • 19. Clostridium difficile infection (CDI) severity and outcome among patients infected with the NAP1/BI/027 strain in a non-epidemic setting.
    Scardina T, Labuszewski L, Pacheco SM, Adams W, Schreckenberger P, Johnson S.
    Infect Control Hosp Epidemiol; 2015 Mar 31; 36(3):280-6. PubMed ID: 25695169
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.